Johnson and Johnson is a leading international pharmaceutical company. In 2025, among its top pharmaceutical products was Darzalex, which earned some  billion U.S. dollars of revenue. Darzalex is a drug used in the treatment of multiple myeloma and light chain amyloidosis.
International pharmaceutical companies
There are several major pharmaceutical companies that are making significant economic impacts globally. In 2024, Johnson & Johnson, AbbVie, and Novartis were the major pharmaceutical companies based on their prescription drug sales globally. When viewed by market capitalization, Johnson and Johnson was the third-ranked global pharmaceutical company, as of 2026.Â
Top pharmaceuticals
The global pharmaceutical industry showed significant growth in revenues over the past two decades. Globally, oncology, diabetes, and immunology are considered the top therapeutic areas for future growth. In 2023, when covid vaccines are excluded, Humira by AbbVie, Keytruda by Merck & Co., and Ozempic by Novo Nordisk were the major drugs based on sales worldwide.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Johnson & Johnson, & U.S. Securities and Exchange Commission. (February 11, 2026). Sales of Johnson & Johnson's top pharmaceutical products from 2022 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 03, 2026, from /statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by-product/
Johnson & Johnson, und U.S. Securities and Exchange Commission. "Sales of Johnson & Johnson's top pharmaceutical products from 2022 to 2025 (in million U.S. dollars)." Chart. February 11, 2026. ÌÇÐÄÆƽâ°æ. Accessed August 03, 2026. /statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by-product/
Johnson & Johnson, U.S. Securities and Exchange Commission. (2026). Sales of Johnson & Johnson's top pharmaceutical products from 2022 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 03, 2026. /statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by-product/
Johnson & Johnson, and U.S. Securities and Exchange Commission. "Sales of Johnson & Johnson's Top Pharmaceutical Products from 2022 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Feb 2026, /statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by-product/
Johnson & Johnson & U.S. Securities and Exchange Commission, Sales of Johnson & Johnson's top pharmaceutical products from 2022 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by-product/ (last visited August 03, 2026)
Sales of Johnson & Johnson's top pharmaceutical products from 2022 to 2025 (in million U.S. dollars) [Graph], Johnson & Johnson, & U.S. Securities and Exchange Commission, February 11, 2026. [Online]. Available: /statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by-product/
